Background and Purpose - Patients with stroke are at substantial risk of thromboembolic
complications and therefore require antithrombotic prophylaxis. To show the noninferiority
of the low-molecular-weight heparin certoparin to unfractionated heparin (UFH) for
the prevention of thromboembolic complications, we performed a randomized, double-blind,
active-controlled multicenter trial in patients with acute ischemic stroke.
